Patents by Inventor Marc S. Hermelin
Marc S. Hermelin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 7687485Abstract: The present disclosure relates to novel compositions which provide improved nutritional support for premenopausal and menopausal women and/or relief from symptoms associated with menopause, as well as prophylactic effects, and methods for using same.Type: GrantFiled: March 27, 2002Date of Patent: March 30, 2010Assignee: Drug Tech CorporationInventors: R. Saul Levinson, Marc S. Hermelin, Mitchell I. Kirschner
-
Publication number: 20090270503Abstract: The present disclosure relates to novel nutritional methods and compositions containing essential fatty acids which optimize embryonic, fetal and child neurological development and provides improved nutritional support for women prior to and during lactation. Further the methods and compositions improve gestational length and birth weight. The nutritional methods and compositions are also intended for use by women to optimize infant neurological development and provide improved nutritional support for women prior to, during and after lactation.Type: ApplicationFiled: October 29, 2008Publication date: October 29, 2009Applicant: DRUGTECH CORPORATIONInventors: Marc S. Hermelin, R. Saul Levinson, George Paradissis
-
Publication number: 20090068289Abstract: The present disclosure relates to novel compositions which provide improved nutritional support for premenopausal and menopausal women and/or relief from systems associated with menopause, as well as prophylactic effects, and methods for using same.Type: ApplicationFiled: November 14, 2008Publication date: March 12, 2009Applicant: DRUGTECH CORPORATIONInventors: R. Saul Levinson, Marc S. Hermelin, Mitchell I. Kirschner
-
Publication number: 20080193531Abstract: The present invention provides pharmaceutical compositions and methods for improving the absorption of nutrients and/or drugs in the gastrointestinal tract of a subject. Typically, the pharmaceutical compositions comprise a first agent that increases the pH of the stomach, and one or more agents selected from a pH lowering agent, a vitamin, a mineral, and a drug.Type: ApplicationFiled: February 7, 2008Publication date: August 14, 2008Applicant: DRUGTECH CORPORATIONInventors: Marc S. Hermelin, Jonathan David Bortz, R. Saul Levinson
-
Patent number: 7112609Abstract: The present disclosure relates to novel nutritional methods and compositions containing essential fatty acids which optimize embryonic, fetal and child neurological development and provide improved nutritional support for women prior to and during lactation. Further the methods and compositions improve gestational length and birth weight. The nutritional methods and compositions are also intended for use by women to optimize infant neurological development and provide improved nutritional support for women prior to, during and after lactation.Type: GrantFiled: June 10, 2003Date of Patent: September 26, 2006Assignee: DrugTech CorporationInventors: Marc S. Hermelin, R. Saul Levinson, George Paradissis
-
Patent number: 6899890Abstract: The present invention relates to a novel essentially pH neutral vaginal drug delivery system suitable for modified delivery of a therapeutically active material in the vaginal cavity. The vaginal drug delivery system comprises an essentially pH neutral emulsion having globules having two phases, an internal water soluble phase and an external water-insoluble phase or film, wherein the water-soluble interior phase contains a therapeutically active drug or drugs. One novel aspect of the vaginal drug delivery system is that the internal water soluble phase comprises an acidic buffered phase.Type: GrantFiled: March 20, 2002Date of Patent: May 31, 2005Assignee: KV Pharmaceutical CompanyInventors: Mitchell I. Kirschner, R. Saul Levinson, Thomas C. Riley, Marc S. Hermelin
-
Patent number: 6793935Abstract: The present invention is directed to a novel flavored extended release composition which forms a non-effervescent suspension when dropped into a liquid, and the methods of using said supplement, thereby minimizing and eliminating gastric discomfort. This flavored extended release composition provides the additional benefits of palatable taste and pleasant appearance.Type: GrantFiled: February 25, 2002Date of Patent: September 21, 2004Assignee: KV Pharmaceutical CompanyInventors: Marc S. Hermelin, George Paradissis, James A. Garegnani
-
Publication number: 20040101554Abstract: This invention relates to novel dosage formulations for nutritional compositions comprising fatty acids derived from both plant and animal sources and methods for minimizing unpleasant taste, regurgitation, gastroesophageal reflux, dyspepsia, nausea, or difficulty in swallowing or ingesting nutritional agents. The nutritional compositions are intended for use by pregnant or lactating women.Type: ApplicationFiled: November 14, 2003Publication date: May 27, 2004Applicant: DrugTech CorporationInventors: Mitchell I. Kirschner, R. Saul Levinson, Marc S. Hermelin
-
Patent number: 6696083Abstract: The efficacy of vitamins and other nutritional agents in treating and preventing various disease states is improved by administering therapeutically effective levels of these agents on a substantially continuous, 24-hour basis. The concentration of lipid peroxides formed by the autoxidation of lipids, and the concentration of oxygen free radicals, are reduced by continuously administering antioxidant agents. The regeneration of nerve tissue is improved by continuously administering at least one pharmaceutically-acceptable B complex vitamin.Type: GrantFiled: January 30, 1998Date of Patent: February 24, 2004Assignee: DrugTech CorporationInventors: George N. Paradissis, R. Saul Levinson, Mitchell I. Kirschner, Marc S. Hermelin
-
Publication number: 20030216351Abstract: The present disclosure relates to novel nutritional methods and compositions containing essential fatty acids which optimize embryonic, fetal and child neurological development and provide improved nutritional support for women prior to and during lactation. Further the methods and compositions improve gestational length and birth weight. The nutritional methods and compositions are also intended for use by women to optimize infant neurological development and provide improved nutritional support for women prior to, during and after lactation.Type: ApplicationFiled: June 10, 2003Publication date: November 20, 2003Applicant: DrugTech CorporationInventors: Marc S. Hermelin, R. Saul Levinson, Geroge Paradissis
-
Publication number: 20030190355Abstract: The present invention is directed to compositions and methods for the enhancement of iron uptake or the treatment of iron deficiency by enhancing the rate and extent of dissolution in a subject in need thereof. The composition contains at least two iron-providing materials in a single dosage form wherein at least one of the iron-providing materials contains a modified release mechanism, matrix, or coating. The iron-providing materials included within the composition have different rates of release. Following administration to the animal, the iron-providing materials are released in the gastrointestinal tract over a period of up to 24 hours.Type: ApplicationFiled: April 5, 2002Publication date: October 9, 2003Inventors: Marc S. Hermelin, Michael Grimshaw
-
Publication number: 20030180366Abstract: The present invention relates to a novel essentially pH neutral vaginal drug delivery system suitable for modified delivery of a therapeutically active material in the vaginal cavity. The vaginal drug delivery system comprises an essentially pH neutral emulsion having globules having two phases, an internal water soluble phase and an external water-insoluble phase or film, wherein the water-soluble interior phase contains a therapeutically active drug or drugs. One novel aspect of the vaginal drug delivery system is that the internal water soluble phase comprises an acidic buffered phase.Type: ApplicationFiled: March 20, 2002Publication date: September 25, 2003Inventors: Mitchell I. Kirschner, R. Saul Levinson, Thomas C. Riley, Marc S. Hermelin
-
Publication number: 20030108605Abstract: The present invention is directed to a novel flavored extended release composition which forms a non-effervescent suspension when dropped into a liquid, and the methods of using said supplement, thereby minimizing and eliminating gastric discomfort. This flavored extended release composition provides the additional benefits of palatable taste and pleasant appearance.Type: ApplicationFiled: December 30, 2002Publication date: June 12, 2003Applicant: KV Pharmaceutical CompanyInventors: Marc S. Hermelin, George Paradissis, James A. Garegnani
-
Patent number: 6576666Abstract: The present disclosure relates to novel nutritional compositions containing linoleic acid and/or linolenic acid which optimize child neurological development and provide improved nutritional support for women prior to and during lactation. The nutritional compositions are intended for use by women to optimize infant neurological development and provide improved nutritional support for women prior to, during and after lactation.Type: GrantFiled: June 21, 2001Date of Patent: June 10, 2003Assignee: Drugtech CorporationInventors: Marc S. Hermelin, R. Saul Levinson, George Paradissis
-
Patent number: 6569857Abstract: The present disclosure relates to novel nutritional compositions and methods for augmenting the possibility of conception while increasing nutritional stores to aid development of healthy embryos and child growth. The nutritional compositions are intended for use by both males and females planning to conceive a child.Type: GrantFiled: May 3, 1999Date of Patent: May 27, 2003Assignee: Drugtech CorporationInventors: Marc S. Hermelin, R. Saul Levinson
-
Publication number: 20020173510Abstract: The present disclosure relates to novel compositions which provide improved nutritional support for premenopausal and menopausal women and/or relief from symptoms associated with menopause, as well as prophylactic effects, and methods for using same.Type: ApplicationFiled: April 25, 2002Publication date: November 21, 2002Applicant: DrugTech CorporationInventors: R. Saul Levinson, Marc S. Hermelin, Mitchell I. Kirschner
-
Patent number: 6479545Abstract: The present disclosure relates to novel compositions which provide improved nutritional support for premenopausal and menopausal women and/or relief from symptoms associated with menopause, as well as prophylactic effects, and methods for using same.Type: GrantFiled: September 30, 1999Date of Patent: November 12, 2002Assignee: Drugtech CorporationInventors: R. Saul Levinson, Marc S. Hermelin, Mitchell I. Kirschner
-
Publication number: 20020137749Abstract: The present disclosure relates to novel compositions which provide improved nutritional support for premenopausal and menopausal women and/or relief from symptoms associated with menopause, as well as prophylactic effects, and methods for using same.Type: ApplicationFiled: March 27, 2002Publication date: September 26, 2002Applicant: DrugTech CorporationInventors: R. Saul Levinson, Marc S. Hermelin, Mitchell I. Kirschner
-
Publication number: 20020119183Abstract: The present invention is directed to a novel flavored extended release composition which forms a non-effervescent suspension when dropped into a liquid, and the methods of using said supplement, thereby minimizing and eliminating gastric discomfort. This flavored extended release composition provides the additional benefits of palatable taste and pleasant appearance.Type: ApplicationFiled: February 25, 2002Publication date: August 29, 2002Applicant: KV Pharmaceutical Co.Inventors: Marc S. Hermelin, George Paradissis, James A. Garegnani
-
Patent number: 6375956Abstract: The present invention relates to a disposable dispensing apparatus which provides optimal therapeutic support to humans and other animals by conveniently supplying a complex dosing regimen requiring simultaneous administration of storage-incompatible or unevenly dosed components in a shelf stable user-friendly format. The present invention is particularly useful for humans with special therapeutic needs, such as pregnant, lactating and/or menopausal women.Type: GrantFiled: July 22, 1999Date of Patent: April 23, 2002Assignee: Drugtech CorporationInventors: Marc S. Hermelin, Mitchell I. Kirschner, Sjoerd Osinga